JAMA Most Cited
http://www.elizeaboutbeauty.com/journals/jama
The Most Cited articles published by JAMA
en-us
Mon, 19 Apr 2021 14:43:29 GMT
Mon, 19 Apr 2021 14:43:29 GMT
Silverchair
jamams@jamanetwork.org
support@www.elizeaboutbeauty.com
-
Clinical Characteristics of Patients With 2019 Novel Coronavirus (2019-nCoV)–Infected Pneumonia in Wuhan, China
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2761044
Tue, 17 Mar 2020 00:00:00 GMT
Wang D, Hu B, Hu C, et al.
This single-center case series describes the demographics, symptoms, laboratory and imaging findings, treatment, and clinical course of 138 patients hospitalized with 2019 novel coronavirus (2019-nCoV)–infected pneumonia (NCIP) in Wuhan, China, highlighting presumed human-to-human hospital-associated transmission in many cases.
323
11
1061
1069
10.1001/jama.2020.1585
2761044
-
The Coronavirus Disease 2019 (COVID-19) Outbreak in China—Summary of a China CDC Report
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2762130
Tue, 07 Apr 2020 00:00:00 GMT
Wu Z, McGoogan JM.
This Viewpoint summarizes key epidemiologic and clinical findings from all cases of coronavirus disease 2019 (COVID-19) reported through February 11, 2020, in mainland China, and case trends in response to government attempts to control and contain the infection.
323
13
1239
1242
10.1001/jama.2020.2648
2762130
-
Clinical Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19 Hospitalized in the NYC Area
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2765184
Tue, 26 May 2020 00:00:00 GMT
Richardson S, Hirsch JS, Narasimhan M, et al.
This case series describes clinical characteristics, health services use, and outcomes of patients with confirmed coronavirus disease 2019 (COVID-19) cared for at 12 hospitals of a single health system in the New York City (NYC) area.
323
20
2052
2059
10.1001/jama.2020.6775
2765184
-
Clarification of Mortality Rate and Data in Abstract, Results, and Table 2
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2765367
Tue, 26 May 2020 00:00:00 GMT
In the Original Investigation titled “Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area�published online April 22, 2020, in JAMA, clarification and correction of data were required. In the Abstract, Results paragraph, the sentence reporting mortality for patients receiving mechanical ventilation should read, “As of April 4, 2020, for patients requiring mechanical ventilation (n = 1151, 20.2%), 38 (3.3%) were discharged alive, 282 (24.5%) died, and 831 (72.2%) remained in hospital.�This same sentence was added to the second paragraph of the Results section in the text. In the first paragraph of the text Results, the sentence about test results should read, “The first test for COVID-19 was positive in 5517 patients (96.8%), while 183 patients (3.2%) had a negative first test and positive repeat test.�In the Discussion, a paragraph was added to clarify the calculation of mortality rates. In Table 2, the number (%) of patients with concurrent entero/rhinovirus infection should be �2 (52.4).�This article has been corrected online.
323
20
2098
2098
10.1001/jama.2020.7681
2765367
-
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2762997
Tue, 12 May 2020 00:00:00 GMT
Wang W, Xu Y, Gao R, et al.
This study describes results of PCR and viral RNA testing for SARS-CoV-2 in bronchoalveolar fluid, sputum, feces, blood, and urine specimens from patients with COVID-19 infection in China to identify possible means of non-respiratory transmission.
323
18
1843
1844
10.1001/jama.2020.3786
2762997
-
Characteristics and Outcomes of Patients Infected With SARS-CoV-2 Admitted to ICUs in Italy
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2764365
Tue, 28 Apr 2020 00:00:00 GMT
Grasselli G, Zangrillo A, Zanella A, et al.
This case series describes the demographics, comorbidities, ventilation requirements, dispositions, and mortality of patients with PCR-confirmed SARS-CoV-2 infection admitted to northern Italy ICUs in February-March 2020..
323
16
1574
1581
10.1001/jama.2020.5394
2764365
-
Presumed Asymptomatic Carrier Transmission of COVID-19
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2762028
Tue, 14 Apr 2020 00:00:00 GMT
Bai Y, Yao L, Wei T, et al.
This study describes possible transmission of novel coronavirus disease 2019 (COVID-19) from an asymptomatic Wuhan resident to 5 family members in Anyang, a Chinese city in the neighboring province of Hubei.
323
14
1406
1407
10.1001/jama.2020.2565
2762028
-
COVID-19 Case-Fatality Rate and Characteristics of Patients Dying in Italy
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2763667
Tue, 12 May 2020 00:00:00 GMT
Onder G, Rezza G, Brusaferro S.
This Viewpoint from physicians with the Italian National Institute of Health confirms a higher case-fatality rate from coronavirus disease 2019 (COVID-19) in Italy compared with China and explains possible reasons, including age, cause of death definitions, and testing strategy.
323
18
1775
1776
10.1001/jama.2020.4683
2763667
-
Treatment of Critically Ill Patients With COVID-19 With Convalescent Plasma
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2763983
Tue, 28 Apr 2020 00:00:00 GMT
Shen C, Wang Z, Zhao F, et al.
This case series describes clinical outcomes in 5 Chinese patients with laboratory-confirmed COVID-19, ARDS, and high viral loads despite antiviral treatment who were given human plasma with SARS-CoV-2 antibodies obtained from previously infected and recovered patients.
323
16
1582
1589
10.1001/jama.2020.4783
2763983
-
Physical Activity Guidelines for Americans
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2712935
Tue, 20 Nov 2018 00:00:00 GMT
Piercy KL, Troiano RP, Ballard RM, et al.
This Special Communication from the US Department of Health and Human Services summarizes key guidelines and recommendations in the Physical Activity Guidelines for Americans, 2nd edition.
320
19
2020
2028
10.1001/jama.2018.14854
2712935
-
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2764727
Tue, 12 May 2020 00:00:00 GMT
Sanders JM, Monogue ML, Jodlowski TZ, et al.
This narrative review summarizes what is currently known about how SARS-CoV-2 infects cells and causes disease as a basis for considering whether chloroquine, remdisivir and other antivirals, or other existing drugs might be effective treatment for coronavirus disease 2019 (COVID-19).
323
18
1824
1836
10.1001/jama.2020.6019
2764727
-
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2762688
Tue, 21 Apr 2020 00:00:00 GMT
Young B, Ong S, Kalimuddin S, et al.
This case series describes the epidemiologic features, clinical presentation, treatment, and outcomes of the first 18 patients with confirmed coronavirus disease 2019 (COVID-19) in Singapore
323
15
1488
1494
10.1001/jama.2020.3204
2762688
-
Characteristics and Outcomes of Critically Ill Patients With COVID-19 in Washington State
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2763485
Tue, 28 Apr 2020 00:00:00 GMT
Arentz M, Yim E, Klaff L, et al.
This case series describes the clinical presentation, characteristics, and outcomes of patients with coronavirus disease 2019 (COVID-19) admitted to the intensive care unit at a public hospital in Washington State in February 2020, including initial reports of cardiomyopathy in one-third of the patients.
323
16
1612
1614
10.1001/jama.2020.4326
2763485
-
Trends in Obesity Prevalence in US Youth and Adults, 2007-2008 to 2015-2016
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2676543
Tue, 24 Apr 2018 00:00:00 GMT
Hales CM, Fryar CD, Carroll MD, et al.
This study uses National Health and Nutrition Examination Survey data to characterize trends in obesity prevalence among US youth and adults between 2007-2008 and 2015-2016.
319
16
1723
1725
10.1001/jama.2018.3060
2676543
-
SARS-CoV-2 Contamination of Air, Environmental Surfaces, and Personal Protective Equipment
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2762692
Tue, 28 Apr 2020 00:00:00 GMT
Ong S, Tan Y, Chia P, et al.
This study documents results of SARS-CoV-2 polymerase chain reaction (PCR) testing of environmental surfaces and personal protective equipment surrounding 3 COVID-19 patients in isolation rooms in a Singapore hospital.
323
16
1610
1612
10.1001/jama.2020.3227
2762692
-
Critical Care and the COVID-19 Outbreak in Italy: Early Experience and Forecast
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2763188
Tue, 28 Apr 2020 00:00:00 GMT
Grasselli G, Pesenti A, Cecconi M.
This Viewpoint describes the organization of a regional ICU network in Lombardy, Italy, to handle the surge in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who require intensive care and uses demand experience in the first 2 weeks of the outbreak to estimate resources required in coming weeks.
323
16
1545
1546
10.1001/jama.2020.4031
2763188
-
Coronavirus Infections—More Than Just the Common Cold
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2759815
Tue, 25 Feb 2020 00:00:00 GMT
Paules CI, Marston HD, Fauci AS.
In this Viewpoint Anthony Fauci and colleagues review the emergence of pathogenic human coronaviruses (SARS-Cov and MERS-CoV) as background for discussing a rapidly spreading novel coronavirus (2019-nCoV) identified in 2019 in China and the public health strategies necessary to contain the threat.
323
8
707
708
10.1001/jama.2020.0757
2759815
-
COVID-19, African Americans, and Health Disparities
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2764789
Tue, 19 May 2020 00:00:00 GMT
Yancy CW.
This Viewpoint discusses the long history of racial inequities that cause black populations in US cities to bear a disproportionate burden of COVID-19 illness and mortality and calls for a renewed commitment to eliminating disparities that have been made so starkly visible by the pandemic.
323
19
1891
1892
10.1001/jama.2020.6548
2764789
-
Breast Cancer Treatment in 2019
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2721183
Tue, 22 Jan 2019 00:00:00 GMT
Waks AG, Winer EP.
This narrative review summarizes current evidence-based approaches to local and systemic treatment of hormone receptor positive/ERBB2 negative (HR+/ERBB2�, ERBB2 positive (ERBB2+), and triple-negative breast cancer.
321
3
288
300
10.1001/jama.2018.19323
2721183
-
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in High-Risk Adults With Diabetes
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2714646
Tue, 01 Jan 2019 00:00:00 GMT
Rosenstock J, Perkovic V, Johansen O, et al.
This randomized clinical trial compares the effects of the dipeptidyl peptidase 4 inhibitor linagliptin vs placebo plus usual care on cardiovascular (CV) and renal outcomes in adults with type 2 diabetes and high CV and renal risk.
321
1
69
79
10.1001/jama.2018.18269
2714646
-
Coronavirus Disease 2019 (COVID-19)—Epidemiology, Diagnosis, and Treatment
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2768391
Tue, 25 Aug 2020 00:00:00 GMT
Wiersinga W, Rhodes A, Cheng AC, et al.
This narrative review discusses what is currently known about the pathophysiology, epidemiology, diagnosis, management, prognosis, and prevention of coronavirus disease 2019 (COVID-19).
324
8
782
793
10.1001/jama.2020.12839
2768391
-
Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2763853
Tue, 12 May 2020 00:00:00 GMT
Dong L, Tian J, He S, et al.
This case report describes birth of an infant with elevated anti–SARS-CoV-2 IgM antibodies and cytokine levels to a mother with polymerase chain reaction–confirmed coronavirus disease 2019 (COVID-19) despite no physical contact.
323
18
1846
1848
10.1001/jama.2020.4621
2763853
-
Treatment With Hydroxychloroquine or Azithromycin and In-Hospital Mortality in Patients With COVID-19
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2766117
Tue, 23 Jun 2020 00:00:00 GMT
Rosenberg ES, Dufort EM, Udo T, et al.
This study examines associations between use of hydroxychloroquine, azithromycin, or both and in-hospital mortality, ECG changes, and cardiac arrest among patients with COVID-19 hospitalized in the metropolitan New York area in March 2020.
323
24
2493
2502
10.1001/jama.2020.8630
2766117
-
Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2762689
Tue, 14 Apr 2020 00:00:00 GMT
Wang C, Ng CY, Brook RH.
This Viewpoint describes the outbreak response infrastructure developed by the Taiwanese government following the SARS epidemic in 2003 and actions in response to COVID-19, including dedicated hotlines for symptom reporting, mobile phone messaging and case tracking, and the ramping up of facemask production.
323
14
1341
1342
10.1001/jama.2020.3151
2762689
-
Public Health Interventions and Epidemiology of the COVID-19 Outbreak in Wuhan, China
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2764658
Tue, 19 May 2020 00:00:00 GMT
Pan A, Liu L, Wang C, et al.
This population epidemiology study examines associations between phases of nonpharmaceutical public health interventions (social distancing, centralized quarantine, home confinement, and others) and rates of laboratory-confirmed COVID-19 infection in Wuhan, China, between December 2019 and early March 2020.
323
19
1915
1923
10.1001/jama.2020.6130
2764658
-
Interpreting Diagnostic Tests for SARS-CoV-2
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2765837
Tue, 09 Jun 2020 00:00:00 GMT
Sethuraman N, Jeremiah S, Ryo A.
This Viewpoint discusses the 2 most common categories of testing to diagnose SARS-CoV-2—real-time PCR to identify viral RNA and serological diagnosis of IgG and IgM antibodies to assess immune response—and estimates time intervals for test positivity by specimen source to help clinicians interpret results relative to symptom onset.
323
22
2249
2251
10.1001/jama.2020.8259
2765837
-
Supporting the Health Care Workforce During the COVID-19 Global Epidemic
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2763136
Tue, 21 Apr 2020 00:00:00 GMT
Adams JG, Walls RM.
This Viewpoint discusses the importance of protecting health care workers caring for patients with coronavirus disease 2019 (COVID-19) and measures that can be taken in and out of the hospital to prevent their and their families�exposure to SARS-CoV-2.
323
15
1439
1440
10.1001/jama.2020.3972
2763136
-
COVID-19 and Racial/Ethnic Disparities
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2766098
Tue, 23 Jun 2020 00:00:00 GMT
Webb Hooper M, N֙poles A, Pérez-Stable EJ.
This Viewpoint reviews possible reasons for reported excess mortality and poor outcomes in racial/ethnic minority populations with COVID-19 and proposes research, public health, and clinical interventions to decrease health inequities in and beyond the pandemic.
323
24
2466
2467
10.1001/jama.2020.8598
2766098
-
The 2019 Novel Coronavirus and Challenges for Global Health Governance
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2760500
Tue, 25 Feb 2020 00:00:00 GMT
Phelan AL, Katz R, Gostin LO.
In this Viewpoint, Gostin and colleagues review the emerging novel coronavirus (2019-nCoV) outbreak, discuss the public health benefits and risks of the Chinese government’s large city quarantines, and call for WHO leadership to coordinate a global coordinated response that could contain this and prevent similar future outbreaks.
323
8
709
710
10.1001/jama.2020.1097
2760500
-
Turbulent Gas Clouds and Respiratory Pathogen Emissions
http://www.elizeaboutbeauty.com/journals/jama/fullarticle/2763852
Tue, 12 May 2020 00:00:00 GMT
Bourouiba L.
This JAMA Insights Clinical Update discusses the need to better understand the dynamics of respiratory disease transmission by better characterizing transmission routes, the role of patient physiology in shaping them, and best approaches for source control in the context of the COVID-19 outbreak.
323
18
1837
1838
10.1001/jama.2020.4756
2763852
4887王中王鉄算 盘开奖结果小说